Related Experiment Videos
Abrogation of c-Raf expression induces apoptosis in tumor cells
Q C Lau1, S Brüsselbach, R Müller
1Institut für Molekularbiologie und Tumorforschung, Philipps-Universität Marburg, Germany.
Abstract:
Signal transduction pathways involving the c-Raf protein kinase are frequently activated in tumor cells. We have addressed the relevance of this activation by a loss-of-function approach. An anti-sense phosphorothioate oligonucleotide (ODN) specifically targeted against c-raf mRNA (Monia et al., 1996a) was used to block c-Raf protein expression in four different cell lines derived from lung, cervical, prostate and colon carcinomas. Concomitant with the abrogation of c-Raf expression we observed the occurrence of classical apoptotic markers, including chromatin condensation, inter-nucleosomal DNA cleavage, annexin V binding and cleavage of PARP, which was followed by cell death, affecting most of the cell population. This induction of apoptosis occurred independent of the p53 status of the cell. These findings demonstrate that c-Raf can protect tumor cells from undergoing programmed cell death, and suggest that the interference with c-Raf expression or function by ODNs or specific drugs could represent a powerful means for improving the efficacy of anti-cancer therapy.
Insights
Blocking c-Raf protein expression using anti-sense oligonucleotides (ODNs) induced apoptosis in various cancer cells. This suggests targeting c-Raf is a promising strategy for anti-cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Signal transduction pathways involving c-Raf kinase are often hyperactivated in cancer cells.
- Understanding the role of c-Raf in tumor cell survival is crucial for developing new therapies.
Purpose of the Study:
- To investigate the functional relevance of c-Raf activation in tumor cells using a loss-of-function approach.
- To determine if inhibiting c-Raf can induce programmed cell death (apoptosis) in cancer cells.
Main Methods:
- Utilized an anti-sense phosphorothioate oligonucleotide (ODN) to specifically target and inhibit c-raf mRNA expression.
- Assessed apoptotic markers (chromatin condensation, DNA cleavage, annexin V binding, PARP cleavage) in four cancer cell lines (lung, cervical, prostate, colon) after c-Raf abrogation.
Main Results:
- Abrogation of c-Raf protein expression led to the induction of classical apoptotic markers and subsequent cell death in all tested cancer cell lines.
- The induction of apoptosis was observed irrespective of the p53 tumor suppressor gene status of the cells.
- c-Raf appears to play a protective role against programmed cell death in tumor cells.
Conclusions:
- c-Raf kinase activity is essential for the survival of various tumor cells.
- Interfering with c-Raf expression or function, for example, with ODNs or targeted drugs, can effectively induce cancer cell death.
- Targeting c-Raf represents a potential therapeutic strategy to enhance the efficacy of anti-cancer treatments.